title: Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.
abstract: alpha-Synuclein is a key component of Lewy bodies found in the brains of patients with Parkinson's disease and two point mutations in this protein, Ala53Thr and Ala30Pro, are associated with rare familial forms of the disease. Several lines of evidence suggest the involvement of oxidative stress in the pathogenesis of nigral neuronal death in Parkinson's disease. In the present work we studied the effects of changes in the alpha-synuclein sequence on the susceptibility of cells to reactive oxygen species. Human dopaminergic neuroblastoma SH-SY5Y cells were stably transduced with various isoforms of alpha-synuclein and their survival following exposure to hydrogen peroxide or to the dopaminergic neurotoxin MPP(+) was assessed. Cells expressing the two point mutant isoforms of alpha-synuclein were significantly more vulnerable to oxidative stress, with the Ala53Thr engineered cells faring the worst. In addition, cells expressing C-terminally truncated alpha-synuclein, particularly the 1-120 residue protein, were more susceptible than control beta-galactosidase engineered cells. The present experiments indicate that point mutations and C-terminal truncation of alpha-synuclein exaggerate the susceptibility of dopaminergic cells to oxidative damage. Thus, these observations provide a pathogenetic link between alpha-synuclein aberrations and a putative cell death mechanism in Parkinson's disease.
authors.affiliation: Genetic Pharmacology Unit, Experimental Therapeutics Branch, NINDS, NIH, Bethesda, MD 20892-1406, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kanda
authors.forename: J F
authors.initials: JF
authors.lastname: Bishop
authors.forename: M A
authors.initials: MA
authors.lastname: Eglitis
authors.forename: Y
authors.initials: Y
authors.lastname: Yang
authors.forename: M M
authors.initials: MM
authors.lastname: Mouradian
mesh_terms: D015655:1-Methyl-4-phenylpyridinium / Q000633:toxicity; D019943:Amino Acid Substitution; D001921:Brain / Q000378:metabolism*; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D016297:Mutagenesis, Site-Directed; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D009447:Neuroblastoma; D018384:Oxidative Stress / Q000187:drug effects; D010750:Phosphoproteins / Q000502:physiology; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D017384:Sequence Deletion; D051843:Synucleins; D014162:Transfection; D014407:Tumor Cells, Cultured; D051844:alpha-Synuclein
chemical_list: D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D011994:Recombinant Proteins; C497604:SNCA protein, human; D051843:Synucleins; D051844:alpha-Synuclein; D006861:Hydrogen Peroxide; D015655:1-Methyl-4-phenylpyridinium